Building Biotech Technology Transfer Opportunities: Sponsor And Developer Strategies For Success

Drug developers have long been under pressure to introduce new products in an environment

of escalating R&D costs, blockbuster patent expiration and resulting generic competition. Current weak economic conditions have exacerbated these challenges with sweeping R&D staff and budget reductions. In order to remain competitive, drug makers must now do more with less. Technology transfer, particularly of new biotechnologies that offer novel means to address unmet medical needs, offer a way to cost effectively address these challenges. They also provide technology developers with a mechanism to monetize their inventions.

However, while some drug makers and technology developers have optimized their biotech tech transfer methodologies and have developed sophisticated processes to select, monitor and manage a wide range of relationships, many other biotech tech transfer projects fail. A large proportion of these failures could be averted as many of the most common reasons for failure are preventable problems relating to due diligence failures, shortcomings in deal structure, management changes, cultural challenges, and inappropriate project organization and expectations. This report provides details on how to avoid these common pitfalls with case studies that illustrate best practices.

Key features of this report

Discussion of the factors leading to current imperatives to increased biotech tech transfer.

Detailed descriptions of both effective and ineffective biotech tech transfer approaches.

In depth analysis of the types of different biotech tech transfer relationships, their advantages and disadvantages.

More than 10 case studies that illustrate biotech tech transfer best practices.

Comprehensive discussion of offshore biotech tech transfer, particularly focusing on India and China.

Scope of this report

Understand the driving forces behind biotech tech transfer.

Save time and money with the reports succinct compilation and analysis of current biotech tech transfer trends.

Learn how biotech tech transfer will evolve over the next several years and why.

Assess your competitive position vis--vis other technology sponsors or technology developers and learn about biotech tech transfer best practices via detailed case studies.

Understand the reasons behind biotech tech transfer success and failure.

Develop strategies to optimize your biotech tech transfer methodologies and protocols.

Key Market Issues

The drug development industry is undergoing a significant change which may permanently re-shape product development activities. Many industry experts believe the industry is shrinking; at the very least, the focus is shifting from large in-house research teams to smart approaches, strategic outsourcing and technology transfer.

Although cost cutting has previously not been a concern for R&D departments, the current economic environment has brought expense reduction programs into research labs. Most of the leading drug makers have recently undertaken and/or are currently in the midst of broad R&D cost cutting programs.

Biotechnology offers a means to address unmet medical needs, particularly via personalized medicine, which small molecule approaches do not. With more than 3,500 biotech drug companies around the world, many have developed unique technologies and approaches to drug development.

Because drug makers must continue to introduce new products, maintaining high productivity is key. Biotech tech transfer offers a means to achieve this by providing technology sponsors with access to new technologies.

Key findings from this report

After a decline in 2008 to 53 deals from 74 deals in 2007, biotech technology transfer volume for human medicines spiked in 2009 to 121 deals. Chapter 1

More than half of biotech tech transfer deals fail. Chapter 2

However, some firms experience very low failure rates of less than 10% while others report very high failure rates in excess of 70%. Chapter 2

Many biotech tech transfer failures can be traced to an inability on the part of the sponsor to adequately perform initial due diligence. Chapter 3

Over the next five years, the role of biotechnology in drug development is expected to expand strongly as biotech drug sales rise by 17.7% per year while small molecule drug sales grow by just 2.9% annually. Chapter 4

Key questions answered

Why is biotech tech transfer rising so quickly? (Because biotechnologies offer a means to address unmet medical needs and many new technologies have been developed outside of Big Pharma)

Which types of biotech tech transfer approaches are currently most common? (Licensing and acquisitions)

Which trends will further boost biotech tech transfer in the future? (Economic recovery, healthcare reform, clarification of biosimilars regulation, rising biotech funding)

What are the most common reasons for the failure of biotech tech transfers? Deficiencies in due diligence, inappropriate deal structure, differing cultures, inappropriate project organization and expectations and technology failure)

To know more about this report & to buy a copy please visit :

http://www.visionshopsters.com/product/3875/Building-Biotech-Technology-Transfer-Opportunities-Sponsor-and-developer-strategies-for-success.html

Contact us:

Visionshopsters

Ph : 91-22-40583020

Emailid: marketing@visionshopsters.com

Website : www.visionshopsters.com

by: Visionshopsters

POST COMMENT

Fast Reading Techniques That Teach People How To Read Faster Apply Special Visual Effects Techniques Nlp Technique - Nlp Anchoring Boston 2010 Bmw Dealers Proud Of Award Winning Technology In Their Cars Cfd Trading Best Techniques Eye Makeup Techniques: How To Look Great Keep Your Sanity In The Technological World Stress Relief Techniques - Discover Your Quiet Mind To See Your Life With True Clarity! Scratches On Hardwood Flooring Removal Techniques Stress Relief Techniques - You May Be Affected By Stress, Without Even Knowing It! Techniques To Stop Plantar Warts Glaze Lost Wax Casting Technology Overview Biometric Fingerprint Access Control System By Raydox Technologies